Hormone therapy and intraocular pressure in nonglaucomatous eyes

Menopause

Volumn 17, Issue 1, 2010, Pages 157-160

  Tint, Naing L ^a,b   Alexander, Philip ^a   Tint, Khin M ^b   Vasileiadis, George T ^b   Yeung, Aaron M ^b   Azuara Blanco, Augusto ^c  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Glaucoma; Hormone therapy; Intraocular pressure; Menopause.

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; EYE DISEASE; FAMILY HISTORY; FEMALE; GLAUCOMA; HORMONAL THERAPY; HUMAN; INTRAOCULAR PRESSURE; POSTMENOPAUSE; REFRACTION ERROR; TONOMETRY;

AGED; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; PROGESTERONE; PROSPECTIVE STUDIES;

EID: 74549128532     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181b82fb4     Document Type: Article

References (21)

1. Canderelli R, Leccesse L, Miller NL, Unruh Davidson J. Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract 2007;19:635-641.
2. Gupta PD, Johar K, Nagpal K, et al. Sex hormone receptors in the human eye. Surv Ophthalmol 2005;50:274-285.
3. Salvati AL. Influence de la menstruation sur la tension oculaire. Ann Ocul 1923;160:568-569.
4. Avasthi P, Luthra MC. Effect of sex hormones on intraocular pressure. Int Surg 1967;48:350-355.
5. Uncu G, Avci R, Uncu Y, et al. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006;22:501-505.
6. Altintas O, Caglar Y, Yuksel N, et al. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004;218:120-129.
7. Affinito P, Di Spiezio Sardo A, Di Carlo C, et al. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause 2003;10:482-487.
8. Sator MO, Akramian J, Joura EA, et al. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998;29:93-95.
9. Sator MO, Joura EA, Frigo P, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55-58.
10. Abramov Y, Borik S, Yahalom C, et al. Does postmenopausal hormone replacement therapy affect intraocular pressure? J Glaucoma 2005;14: 271-275.
11. Toker E, Yenice O, Temel A. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma 2003;12: 436-440.
12. Khurana RN, LeBree LD, Scott G, et al. Esterified oestrogens combined with methyltestosterone raise intraocular pressure in postmenopausal women. Am J Ophthalmol 2006;142:494-495.
13. Ganley JP. Epidemiological aspects of ocular hypertension. Surv Ophthalmol 1980;25:563-570.
14. Imre J. Die regulatorische Wirkung der endokrinen Drusen auf den intraokularen Druck. Arch Augenheilkd 1921;88:155-157.
15. Ofri R, Shore LS, Kass PH et al. The effect of elevated progesterone levels on intraocular pressure in lions (Panthera leo). Res Vet Sci 1999; 67:121-123.
16. Green K, Cheeks L, Slagle T. Interaction between progesterone and mifepristone on intraocular pressure in rabbits. Curr Eye Res 1989;8: 317-320.
17. Guaschino S, Grimaldi E, Sartore A, et al. Visual function in menopause: the role of hormone replacement therapy. Menopause 2003; 10:53-57.
18. Verit FF, Oguz H, Ozkul Y et al. Long-term effects of tibolone on ocular functions in postmenopausal women. Arch Gynecol Obstet 2007;275: 255-261.
19. Leach NE, Wallis NE, Lothringer LL, et al. Corneal hydration changes during the normal menstrual cycle. A preliminary study. J Reprod Med 1971;6:15-18.
20. Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988;105:258-260.
21. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;81:286-293. (Pubitemid 36806269)